Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Specifications Specifications RUO Research Use Only By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form
The phase 3 ATTAIN-1 trial compared results for 3127 adult participants with obesity, or who were overweight with a weight-related medical problem, and who did not have diabetes
Impact of Semaglutide on Fat Mass, Lean Mass and Muscle Function in Patients With Obesity: The SEMALEAN study
Gallery References Fraenkel L, Bathon JM, England BR, et al
Masood W et al
Anyone experiencing: Persistent muscle or joint pain
US$ 25.09
US$ 28.82
US$ 22.36
US$ 26.07
